Elevated GSDMD levels are associated with advanced TNM stages in NSCLC patients, and its knockdown inhibits tumor growth by activating the mitochondrial apoptotic pathway and suppressing the EGFR/AKT signaling pathway [212]. This evidence concerns the gene GSDMD and neoplasm.